PS
Patricia Susan Andrews
About Patricia Susan Andrews
Data last updated:
Patricia Susan Andrews is a Director at Glenmark Pharmaceuticals Limited (since 2025). The company operates in Pharma. Glenmark Pharmaceuticals Limited reported revenue of ₹17,443 Cr (FY 2026).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Glenmark Pharmaceuticals Limited L24299MH1977PLC019982 | Director | 14 Aug 2025 | 1977 | ₹17,443 Cr (FY 2026) | Active |
Board colleagues of Patricia Susan Andrews
| Name | DIN | Company | Designation |
|---|---|---|---|
| Anurag Mantri | 05326463 | Glenmark Pharmaceuticals Limited | Whole-Time Director |
| Anurag Mantri | Glenmark Pharmaceuticals Limited | Cfo | |
| Blanche Saldanha Elizabeth | 00007671 | Glenmark Pharmaceuticals Limited | Director |
| Cherylann Maria Pinto | 00111844 | Glenmark Pharmaceuticals Limited | Whole-Time Director |
| Dipankar Bhattacharjee | 08770548 | Glenmark Pharmaceuticals Limited | Director |
| Glenn Mario Saldanha | 00050607 | Glenmark Pharmaceuticals Limited | Managing Director |
| Pradeep Kumar Sinha | 00145126 | Glenmark Pharmaceuticals Limited | Director |
| Rashmi Khandelwal | Glenmark Pharmaceuticals Limited | Company Secretary | |
| Sona Saira Ramasastry | 08398547 | Glenmark Pharmaceuticals Limited | Director |
| Vijayalakshmi Iyer | 05242960 | Glenmark Pharmaceuticals Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Patricia Susan Andrews
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Patricia Susan Andrews
Patricia Susan Andrews currently holds 1 directorship: Glenmark Pharmaceuticals Limited (Director, since 14 Aug 2025, revenue ₹17,443 Cr (FY 2026)).
Patricia Susan Andrews was first appointed on 14 Aug 2025 as Director at Glenmark Pharmaceuticals Limited.
The current boards of Patricia Susan Andrews's companies include Anurag Mantri (Glenmark Pharmaceuticals Limited), Anurag Mantri (Glenmark Pharmaceuticals Limited), Blanche Saldanha Elizabeth (Glenmark Pharmaceuticals Limited), Cherylann Maria Pinto (Glenmark Pharmaceuticals Limited), Dipankar Bhattacharjee (Glenmark Pharmaceuticals Limited), Glenn Mario Saldanha (Glenmark Pharmaceuticals Limited), among others.